The ecology and evolution of microbial CRISPR-Cas adaptive immune systems

References

• 1.
  Adli M. 2018The CRISPR tool kit for genome editing and beyond. Nat. Commun. 9, 1911. (doi:10.1038/s41467-018-04252-2) Crossref, PubMed, ISI, Google Scholar
• 2.
  Selle K, Barrangou R. 2015CRISPR-based technologies and the future of food science. J. Food Sci. 80, R2367-R2372. (doi:10.1111/1750-3841.13094). Crossref, PubMed, ISI, Google Scholar
• 3.
  Pursey E, Sunderhauf D, Gaze WH, Westra ER, van Houte S.2018CRISPR-Cas antimicrobials: challenges and future prospects. PLoS Pathog. 14, e1006990. (doi:10.1371/journal.ppat.1006990). Crossref, PubMed, ISI, Google Scholar
• 4.
  Noble C, Adlam B, Church GM, Esvelt KM, Nowak MA. 2018Current CRISPR gene drive systems are likely to be highly invasive in wild populations. Elife 7, e33423. (doi:10.7554/eLife.33423) Crossref, PubMed, ISI, Google Scholar
• 5.
  Webber BL, Raghu S, Edwards OR. 2015Opinion: Is CRISPR-based gene drive a biocontrol silver bullet or global conservation threat?Proc. Natl Acad. Sci. USA 112, 10 565-10 567. (doi:10.1073/pnas.1514258112) Crossref, ISI, Google Scholar
• 6.
  Akbari OSet al.. 2015BIOSAFETY. Safeguarding gene drive experiments in the laboratory. Science 349, 927-929. (doi:10.1126/science.aac7932) Crossref, PubMed, ISI, Google Scholar
• 7.
  Brokowski C, Adli M. 2019CRISPR ethics: moral considerations for applications of a powerful tool. J. Mol. Biol. 431, 88-101. (doi:10.1016/j.jmb.2018.05.044) Crossref, PubMed, ISI, Google Scholar
• 8.
  Mojica FJ, Diez-Villasenor C, Garcia-Martinez J, Soria E. 2005Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J. Mol. Evol. 60, 174-182. (doi:10.1007/s00239-004-0046-3) Crossref, PubMed, ISI, Google Scholar
• 9.
  Bolotin A, Quinquis B, Sorokin A, Ehrlich SD. 2005Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology 151, 2551-2561. (doi:10.1099/mic.0.28048-0) Crossref, PubMed, ISI, Google Scholar
• 10.
  Pourcel C, Salvignol G, Vergnaud G. 2005CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiology 151, 653-663. (doi:10.1099/mic.0.27437-0) Crossref, PubMed, ISI, Google Scholar
• 11.
  Makarova KS, Grishin NV, Shabalina SA, Wolf YI, Koonin EV. 2006A putative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action. Biol. Direct 1, 7. (doi:10.1186/1745-6150-1-7) Crossref, PubMed, ISI, Google Scholar
• 12.
  Grissa I, Vergnaud G, Pourcel C. 2007The CRISPRdb database and tools to display CRISPRs and to generate dictionaries of spacers and repeats. BMC Bioinf. 8, 172. (doi:10.1186/1471-2105-8-172) Crossref, PubMed, ISI, Google Scholar
• 13.
  Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, Romero DA, Horvath P. 2007CRISPR provides acquired resistance against viruses in prokaryotes. Science 315, 1709-1712. (doi:10.1126/science.1138140) Crossref, PubMed, ISI, Google Scholar
• 14.
  Marraffini LA, Sontheimer EJ. 2008CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science 322, 1843-1845. (doi:10.1126/science.1165771) Crossref, PubMed, ISI, Google Scholar
• 15.
  Amitai G, Sorek R. 2016CRISPR–Cas adaptation: insights into the mechanism of action. Nat. Rev. Microbiol. 14, 67-76. (doi:10.1038/nrmicro.2015.14) Crossref, PubMed, ISI, Google Scholar
• 16.
  Westra ER, Dowling AJ, Broniewski JM, van Houte S.2016Evolution and ecology of CRISPR. Annu. Rev. Ecol. Evol. Syst. 47, 307-331. (doi:10.1146/annurev-ecolsys-121415-032428) Crossref, ISI, Google Scholar
• 17.
  Vale PF, Little TJ. 2010CRISPR-mediated phage resistance and the ghost of coevolution past. Proc. R. Soc. B 277, 2097-2103. (doi:10.1098/rspb.2010.0055) Link, ISI, Google Scholar
• 18.
  Jansen R, Embden JD, Gaastra W, Schouls LM. 2002Identification of genes that are associated with DNA repeats in prokaryotes. Mol. Microbiol. 43, 1565-1575. (doi:10.1046/j.1365-2958.2002.02839.x) Crossref, PubMed, ISI, Google Scholar
• 19.
  Shmakov SA, Makarova KS, Wolf YI, Severinov KV, Koonin EV. 2018Systematic prediction of genes functionally linked to CRISPR-Cas systems by gene neighborhood analysis. Proc. Natl Acad. Sci. USA 115, E5307-E5316. (doi:10.1073/pnas.1803440115) Crossref, PubMed, ISI, Google Scholar
• 20.
  Shmakov Set al.2017Diversity and evolution of class 2 CRISPR–Cas systems. Nat. Rev. Microbiol. 15, 169-182. (doi:10.1038/nrmicro.2016.184) Crossref, PubMed, ISI, Google Scholar
• 21.
  Koonin EV, Makarova KS, Zhang F. 2017Diversity, classification and evolution of CRISPR-Cas systems. Curr. Opin. Microbiol. 37, 67-78. (doi:10.1016/j.mib.2017.05.008) Crossref, PubMed, ISI, Google Scholar
• 22.
  Makarova KSet al.2015An updated evolutionary classification of CRISPR–Cas systems. Nat. Rev. Microbiol. 13, 722-736. (doi:10.1038/nrmicro3569) Crossref, PubMed, ISI, Google Scholar
• 23.
  van der Oost J, Westra ER, Jackson RN, Wiedenheft B.2014Unravelling the structural and mechanistic basis of CRISPR–Cas systems. Nat. Rev. Microbiol. 12, 479-492. (doi:10.1038/nrmicro3279) Crossref, PubMed, ISI, Google Scholar
• 24.
  Marraffini LA. 2015CRISPR–Cas immunity in prokaryotes. Nature 526, 55-61. (doi:10.1038/nature15386) Crossref, PubMed, ISI, Google Scholar
• 25.
  Jackson SA, McKenzie RE, Fagerlund RD, Kieper SN, Fineran PC, Brouns SJ. 2017CRISPR-Cas: adapting to change. Science 356, aa15056. (doi:10.1126/science.aal5056) Crossref, ISI, Google Scholar
• 26.
  Charpentier E, Richter H, van der Oost J, White MF.2015Biogenesis pathways of RNA guides in archaeal and bacterial CRISPR–Cas adaptive immunity. FEMS Microbiol. Rev. 39, 428-441. (doi:10.1093/femsre/fuv023) Crossref, PubMed, ISI, Google Scholar
• 27.
  Weinberger AD, Wolf YI, Lobkovsky AE, Gilmore MS, Koonin EV. 2012Viral diversity threshold for adaptive immunity in prokaryotes. MBio 3, e00456-12. (doi:10.1128/mBio.00456-12) Crossref, PubMed, ISI, Google Scholar
• 28.
  Iranzo J, Lobkovsky AE, Wolf YI, Koonin EV. 2013Evolutionary dynamics of the prokaryotic adaptive immunity system CRISPR-Cas in an explicit ecological context. J. Bacteriol. 195, 3834-3844. (doi:10.1128/JB.00412-13) Crossref, PubMed, ISI, Google Scholar
• 29.
  Anderson RE, Brazelton WJ, Baross JA. 2011Using CRISPRs as a metagenomic tool to identify microbial hosts of a diffuse flow hydrothermal vent viral assemblage. FEMS Microbiol. Ecol. 77, 120-133. (doi:10.1111/j.1574-6941.2011.01090.x) Crossref, PubMed, ISI, Google Scholar
• 30.
  Burstein D, Sun CL, Brown CT, Sharon I, Anantharaman K, Probst AJ, Thomas BC, Banfield JF. 2016Major bacterial lineages are essentially devoid of CRISPR–Cas viral defence systems. Nat. Commun. 7, 10613. (doi:10.1038/ncomms10613) Crossref, PubMed, ISI, Google Scholar
• 31.
  Weissman J, Laljani R, Fagan W, Johnson P. 2018Ecology shapes microbial immune strategy: temperature and oxygen as determinants of the incidence of CRISPR adaptive immunity. biorxiv. (doi:10.1101/326330) Google Scholar
• 32.
  van Houte S, Buckling A, Westra ER.2016Evolutionary ecology of prokaryotic immune mechanisms. Microbiol. Mol. Biol. Rev. 80, 745-763. (doi:10.1128/MMBR.00011-16) Crossref, PubMed, ISI, Google Scholar
• 33.
  Westra ERet al.2015Parasite exposure drives selective evolution of constitutive versus inducible defense. Curr. Biol. 25, 1043-1049. (doi:10.1016/j.cub.2015.01.065) Crossref, PubMed, ISI, Google Scholar
• 34.
  Chabas H, van Houte S, Hoyland-Kroghsbo NM, Buckling A, Westra ER.2016Immigration of susceptible hosts triggers the evolution of alternative parasite defence strategies. Proc. R. Soc. B 283, 20160721. (doi:10.1098/rspb.2016.0721) Link, ISI, Google Scholar
• 35.
  Vercoe RBet al.2013Cytotoxic chromosomal targeting by CRISPR/Cas systems can reshape bacterial genomes and expel or remodel pathogenicity islands. PLoS Genet. 9, e1003454. (doi:10.1371/journal.pgen.1003454) Crossref, PubMed, ISI, Google Scholar
• 36.
  Stern A, Keren L, Wurtzel O, Amitai G, Sorek R. 2010Self-targeting by CRISPR: gene regulation or autoimmunity?Trends Genet. 26, 335-340. (doi:10.1016/j.tig.2010.05.008) Crossref, PubMed, ISI, Google Scholar
• 37.
  Bikard D, Hatoum-Aslan A, Mucida D, Marraffini LA. 2012CRISPR interference can prevent natural transformation and virulence acquisition during in vivo bacterial infection. Cell Host Microbe 12, 177-186. (doi:10.1016/j.chom.2012.06.003) Crossref, PubMed, ISI, Google Scholar
• 38.
  van Sluijs L, van Houte S, van der Oost J, Brouns SJ, Buckling A, Westra ER. In press. Addiction systems antagonize bacterial adaptive immunity. FEMS Microbiol. Lett. Google Scholar
• 39.
  Bernheim A, Calvo-Villamanan A, Basier C, Cui L, Rocha E.PC, Touchon M, Bikard D. 2017Inhibition of NHEJ repair by type II-A CRISPR–Cas systems in bacteria. Nat. Commun. 8, 2094. (doi:10.1038/s41467-017-02350-1) Crossref, PubMed, ISI, Google Scholar
• 40.
  Levy A, Goren MG, Yosef I, Auster O, Manor M, Amitai G, Edgar R, Qimron U, Sorek R. 2015CRISPR adaptation biases explain preference for acquisition of foreign DNA. Nature 520, 505-510. (doi:10.1038/nature14302) Crossref, PubMed, ISI, Google Scholar
• 41.
  Paez-Espino D, Sharon I, Morovic W, Stahl B, Thomas BC, Barrangou R, Banfield JF. 2015CRISPR immunity drives rapid phage genome evolution in Streptococcus thermophilus. MBio 6, e00262-15. (doi:10.1128/mBio.00262-15) Crossref, PubMed, ISI, Google Scholar
• 42.
  van Houte Set al.2016The diversity-generating benefits of a prokaryotic adaptive immune system. Nature 532, 385-388. (doi:10.1038/nature17436) Crossref, PubMed, ISI, Google Scholar
• 43.
  Andersson AF, Banfield JF. 2008Virus population dynamics and acquired virus resistance in natural microbial communities. Science 320, 1047-1050. (doi:10.1126/science.1157358) Crossref, PubMed, ISI, Google Scholar
• 44.
  Held NL, Herrera A, Whitaker RJ. 2013Reassortment of CRISPR repeat-spacer loci in Sulfolobus islandicus. Environ. Microbiol. 15, 3065-3076. (doi:10.1111/1462-2920.12146) PubMed, ISI, Google Scholar
• 45.
  Tyson GW, Banfield JF. 2008Rapidly evolving CRISPRs implicated in acquired resistance of microorganisms to viruses. Environ. Microbiol. 10, 200-207. (doi:10.1111/j.1462-2920.2007.01444.x) PubMed, ISI, Google Scholar
• 46.
  Held NL, Herrera A, Cadillo-Quiroz H, Whitaker RJ. 2010CRISPR associated diversity within a population of Sulfolobus islandicus. PLoS ONE 5, e0012988. (doi:10.1371/journal.pone.0012988) Crossref, PubMed, ISI, Google Scholar
• 47.
  Emerson JB, Andrade K, Thomas BC, Norman A, Allen EE, Heidelberg KB, Banfield JF. 2013Virus-host and CRISPR dynamics in Archaea-dominated hypersaline Lake Tyrrell, Victoria, Australia. Archaea 2013, 370871. (doi:10.1155/2013/370871) Crossref, PubMed, ISI, Google Scholar
• 48.
  Tomida J, Morita Y, Shibayama K, Kikuchi K, Sawa T, Akaike T, Kawamura Y. 2017Diversity and microevolution of CRISPR loci in Helicobacter cinaedi. PLoS ONE 12, e0186241. (doi:10.1371/journal.pone.0186241) Crossref, PubMed, ISI, Google Scholar
• 49.
  England WE, Kim T, Whitaker RJ. 2018Metapopulation structure of CRISPR-Cas immunity in Pseudomonas aeruginosa and its viruses. mSystems 3, e00075-18. (doi:10.1128/mSystems.00075-18) Crossref, PubMed, ISI, Google Scholar
• 50.
  Devoto AEet al.In press. Megaphages infect Prevotella and variants are widespread in gut microbiomes. Nat. Microbiol. (doi:10.1038/s41564-018-0338-9) Google Scholar
• 51.
  Common J, Westra ER. 2019CRISPR evolution and bacteriophage persistence in the context of population bottlenecks. RNA Biol. 5, 1-7. (doi:10.1080/15476286.2019.1578608) Crossref, Google Scholar
• 52.
  Touchon M, Rocha EP. 2010The small, slow and specialized CRISPR and anti-CRISPR of Escherichia and Salmonella. PLoS ONE 5, e11126. (doi:10.1371/journal.pone.0011126) Crossref, PubMed, ISI, Google Scholar
• 53.
  Semenova E, Jore MM, Datsenko KA, Semenova A, Westra ER, Wanner B, van der Oost J, Brouns SJ, Severinov K.2011Interference by clustered regularly interspaced short palindromic repeat (CRISPR) RNA is governed by a seed sequence. Proc. Natl Acad. Sci. USA 108, 10 098-10 103. (doi:10.1073/pnas.1104144108) Crossref, ISI, Google Scholar
• 54.
  Deveau H, Barrangou R, Garneau JE, Labonte J, Fremaux C, Boyaval P, Romero DA, Horvath P, Moineau S. 2008Phage response to CRISPR-encoded resistance in Streptococcus thermophilus. J. Bacteriol. 190, 1390-1400. (doi:10.1128/JB.01412-07) Crossref, PubMed, ISI, Google Scholar
• 55.
  Levin BR, Moineau S, Bushman M, Barrangou R. 2013The population and evolutionary dynamics of phage and bacteria with CRISPR-mediated immunity. PLoS Genet. 9, e1003312. (doi:10.1371/journal.pgen.1003312) Crossref, PubMed, ISI, Google Scholar
• 56.
  Childs LM, England WE, Young MJ, Weitz JS, Whitaker RJ. 2014CRISPR-induced distributed immunity in microbial populations. PLoS ONE 9, e101710. (doi:10.1371/journal.pone.0101710) Crossref, PubMed, ISI, Google Scholar
• 57.
  Chabas H, Lion S, Nicot A, Meaden S, van Houte S, Moineau S, Wahl LM, Westra ER, Gandon S.2018Evolutionary emergence of infectious diseases in heterogeneous host populations. PLoS Biol. 16, e2006738. (doi:10.1371/journal.pbio.2006738) Crossref, PubMed, ISI, Google Scholar
• 58.
  Westra ER, Sunderhauf D, Landsberger M, Buckling A. 2017Mechanisms and consequences of diversity-generating immune strategies. Nat. Rev. Immunol. 17, 719-728. (doi:10.1038/nri.2017.78) Crossref, PubMed, ISI, Google Scholar
• 59.
  Bondy-Denomy J, Pawluk A, Maxwell KL, Davidson AR. 2013Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system. Nature 493, 429-432. (doi:10.1038/nature11723) Crossref, PubMed, ISI, Google Scholar
• 60.
  Borges AL, Zhang JY, Rollins MF, Osuna BA, Wiedenheft B, Bondy-Denomy J. 2018Bacteriophage cooperation suppresses CRISPR-Cas3 and Cas9 immunity. Cell 174, 917-925. (doi:10.1016/j.cell.2018.06.013) Crossref, PubMed, ISI, Google Scholar
• 61.
  Landsberger M, Gandon S, Meaden S, Rollie C, Chevallereau A, Chabas H, Buckling A, Westra ER, van Houte S.2018Anti-CRISPR phages cooperate to overcome CRISPR-Cas immunity. Cell 174, 908-916. (doi:10.1016/j.cell.2018.05.058) Crossref, PubMed, ISI, Google Scholar
• 62.
  Vale PF, Lafforgue G, Gatchitch F, Gardan R, Moineau S, Gandon S. 2015Costs of CRISPR-Cas-mediated resistance in Streptococcus thermophilus. Proc. R. Soc. B 282, 20151270. (doi:10.1098/rspb.2015.1270) Link, ISI, Google Scholar
• 63.
  Palmer KL, Gilmore MS. 2010Multidrug-resistant enterococci lack CRISPR-cas. MBio 1, e00227-10. (doi:10.1128/mBio.00227-10) Crossref, PubMed, ISI, Google Scholar
• 64.
  Jiang W, Maniv I, Arain F, Wang Y, Levin BR, Marraffini LA. 2013Dealing with the evolutionary downside of CRISPR immunity: bacteria and beneficial plasmids. PLoS Genet. 9, e1003844. (doi:10.1371/journal.pgen.1003844) Crossref, PubMed, ISI, Google Scholar
• 65.
  Gandon S, Vale PF. 2014The evolution of resistance against good and bad infections. J. Evol. Biol. 27, 303-312. (doi:10.1111/jeb.12291) Crossref, PubMed, ISI, Google Scholar
• 66.
  Paez-Espino D, Morovic W, Sun CL, Thomas BC, Ueda K, Stahl B, Barrangou R, Banfield JF. 2013Strong bias in the bacterial CRISPR elements that confer immunity to phage. Nat. Commun. 4, 1430. (doi:10.1038/ncomms2440) Crossref, PubMed, ISI, Google Scholar
• 67.
  Citorik RJ, Mimee M, Lu TK. 2014Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases. Nat. Biotechnol. 32, 1141-1145. (doi:10.1038/nbt.3011) Crossref, PubMed, ISI, Google Scholar
• 68.
  Gomaa AA, Klumpe HE, Luo ML, Selle K, Barrangou R, Beisel CL. 2013Programmable removal of bacterial strains by use of genome-targeting CRISPR-Cas systems. MBio 5, e00928–13. (doi:10.1128/mBio.00928-13) Crossref, ISI, Google Scholar
• 69.
  Bikard D, Euler CW, Jiang W, Nussenzweig PM, Goldberg GW, Duportet X, Fischetti VA, Marraffini LA. 2014Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials. Nat. Biotechnol. 32, 1146-1150. (doi:10.1038/nbt.3043) Crossref, PubMed, ISI, Google Scholar
• 70.
  Dong H, Xiang H, Mu D, Wang D, Wang T. 2019Exploiting a conjugative CRISPR/Cas9 system to eliminate plasmid harbouring the mcr-1 gene from Escherichia coli. Int. J. Antimicrob. Agents 53, 1-8. (doi:10.1016/j.ijantimicag.2018.09.017) Crossref, PubMed, ISI, Google Scholar
• 71.
  Buchthal J, Evans SW, Lunshof J, Telford SR, Esvelt KM. 2019Mice Against Ticks: an experimental community-guided effort to prevent tick-borne disease by altering the shared environment. Phil. Trans. R. Soc. B 374, 20180105. (doi:10.1098/rstb.2018.0105) Link, Google Scholar
• 72.
  Esvelt KM, Smidler AL, Catteruccia F, Church GM. 2014Concerning RNA-guided gene drives for the alteration of wild populations. Elife 3, e03401. (doi:10.7554/eLife.03401) Crossref, PubMed, ISI, Google Scholar
• 73.
  Godfray H.CJ, North A, Burt A. 2017How driving endonuclease genes can be used to combat pests and disease vectors. BMC Biol. 15, 81. (doi:10.1186/s12915-017-0420-4) Crossref, PubMed, ISI, Google Scholar
• 74.
  DiCarlo JE, Chavez A, Dietz SL, Esvelt KM, Church GM. 2015Safeguarding CRISPR–Cas9 gene drives in yeast. Nat. Biotechnol. 33, 1250-1255. (doi:10.1038/nbt.3412) Crossref, PubMed, ISI, Google Scholar
• 75.
  Gantz VM, Jasinskiene N, Tatarenkova O, Fazekas A, Macias VM, Bier E, James AA. 2015Highly efficient Cas9-mediated gene drive for population modification of the malaria vector mosquito Anopheles stephensi. Proc. Natl Acad. Sci. USA 112, E6736-E6743. (doi:10.1073/pnas.1521077112) Crossref, PubMed, ISI, Google Scholar
• 76.
  Gantz VM, Bier E. 2015Genome editing. The mutagenic chain reaction: a method for converting heterozygous to homozygous mutations. Science 348, 442-444. (doi:10.1126/science.aaa5945) Crossref, PubMed, ISI, Google Scholar
• 77.
  Grunwald HA, Gantz VM, Poplawski G, Xu XS, Bier E, Cooper KL. 2019Super-Mendelian inheritance mediated by CRISPR–Cas9 in the female mouse germline. Nature 566, 105-109. (doi:10.1038/s41586-019-0875-2) Crossref, PubMed, ISI, Google Scholar
• 78.
  Champer J, Liu J, Oh SY, Reeves R, Luthra A, Oakes N, Clark AG, Messer PW. 2018Reducing resistance allele formation in CRISPR gene drive. Proc. Natl Acad. Sci. USA 115, 5522-5527. (doi:10.1073/pnas.1720354115) Crossref, PubMed, ISI, Google Scholar
• 79.
  Unckless RL, Clark AG, Messer PW. 2017Evolution of resistance against CRISPR/Cas9 gene drive. Genetics 205, 827-841. (doi:10.1534/genetics.116.197285) Crossref, PubMed, ISI, Google Scholar
• 80.
  Noble C, Olejarz J, Esvelt K, Church G, Nowak M.2017Evolutionary dynamics of CRISPR gene drives. Sci. Adv. 3, e1601964. (doi:10.1126/sciadv.1601964) Crossref, PubMed, ISI, Google Scholar
• 81.
  Kyrou K, Hammond AM, Galizi R, Kranjc N, Burt A, Beaghton AK, Nolan T, Crisanti A. 2018A CRISPR–Cas9 gene drive targeting doublesex causes complete population suppression in caged Anopheles gambiae mosquitoes. Nat. Biotechnol. 36, 1062-1066. (doi:10.1038/nbt.4245) Crossref, PubMed, ISI, Google Scholar
• 82.
  James Set al.2018Pathway to deployment of gene drive mosquitoes as a potential biocontrol tool for elimination of malaria in sub-Saharan Africa: recommendations of a Scientific Working Group. Am. J. Trop. Med. Hyg. 98(Suppl. 6), 1-49. (doi:10.4269/ajtmh.18-0083) Crossref, PubMed, ISI, Google Scholar
• 83.
  Min J, Smidler AL, Najjar D, Esvelt KM. 2018Harnessing gene drive. J. Responsible Innov. 5(Suppl. 1), S40-S65. (doi:10.1080/23299460.2017.1415586) Crossref, ISI, Google Scholar
• 84.
  National Academies of Sciences Engineering and Medicine. 2016Gene drives on the horizon: advancing science, navigating uncertainty, and aligning research with public values. Washington, DC: The National Academies Press. Google Scholar
• 85.
  Benedict Met al.2014Guidance framework for testing of genetically modified mosquitoes. FNIH, WHO, TDR. See https://manualzz.com/doc/18478798/guidance-framework-for-testing-of-genetically-modified-mosquitoes. Google Scholar
• 86.
  Koonin EV, Makarova KS. 2019Origins and evolution of CRISPR-Cas systems. Phil. Trans. R. Soc. B 374, 20180087. (doi:10.1098/rstb.2018.0087) Link, ISI, Google Scholar
• 87.
  Gurney J, Pleška M, Levin BR. 2019Why put up with immunity when there is resistance: an excursion into the population and evolutionary dynamics of restriction–modification and CRISPR-Cas. Phil. Trans. R. Soc. B 374, 20180096. (doi:10.1098/rstb.2018.0096) Link, Google Scholar
• 88.
  Bernheim A, Bikard D, Touchon M, Rocha EPC. 2019A matter of background: DNA repair pathways as a possible cause for the sparse distribution of CRISPR-Cas systems in bacteria. Phil. Trans. R. Soc. B 374, 20180088. (doi:10.1098/rstb.2018.0088) Link, Google Scholar
• 89.
  Chevallereau A, Meaden S, van Houte S, Westra ER, Rollie C.2019The effect of bacterial mutation rate on the evolution of CRISPR-Cas adaptive immunity. Phil. Trans. R. Soc. B 374, 20180094. (doi:10.1098/rstb.2018.0094) Link, Google Scholar
• 90.
  Bradde S, Mora T, Walczak AM. 2019Cost and benefits of clustered regularly interspaced short palindromic repeats spacer acquisition. Phil. Trans. R. Soc. B 374, 20180095. (doi:10.1098/rstb.2018.0095) Link, Google Scholar
• 91.
  Lopatina A, Medvedeva S, Artamonova D, Kolesnik M, Sitnik V, Ispolatov Y, Severinov K. 2019Natural diversity of CRISPR spacers of Thermus: evidence of local spacer acquisition and global spacer exchange. Phil. Trans. R. Soc. B 374, 20180092. (doi:10.1098/rstb.2018.0092) Link, Google Scholar
• 92.
  Pauly MD, Bautista MA, Black JA, Whitaker RJ. 2019Diversified local CRISPR-Cas immunity to viruses of Sulfolobus islandicus. Phil. Trans. R. Soc. B 374, 20180093. (doi:10.1098/rstb.2018.0093) Link, Google Scholar
• 93.
  Hoikkala V, Almeida GMF, Laanto E, Sundberg L-R. 2019Aquaculture as a source of empirical evidence for coevolution between CRISPR-Cas and phage. Phil. Trans. R. Soc. B 374, 20180100. (doi:10.1098/rstb.2018.0100) Link, Google Scholar
• 94.
  Common J, Morley D, Westra ER, van Houte S. 2019 CRISPR-Cas immunity leads to a coevolutionary arms race between Streptococcus thermophilus and lytic phage. Phil. Trans. R. Soc. B 374, 20180098. (doi:10.1098/rstb.2018.0098) Google Scholar
• 95.
  Chabas H, Nicot A, Meaden S, Westra ER, Tremblay DM, Pradier L, Lion S, Moineau S, Gandon S. 2019Variability in the durability of CRISPR-Cas immunity. Phil. Trans. R. Soc. B 374, 20180097. (doi:10.1098/rstb.2018.0097) Link, Google Scholar
• 96.
  Watson BNJ, Easingwood RA, Tong B, Wolf M, Salmond GPC, Staals RHJ, Bostina M, Fineran PC. 2019Different genetic and morphological outcomes for phages targeted by single or multiple CRISPR-Cas spacers. Phil. Trans. R. Soc. B 374, 20180090. (doi:10.1098/rstb.2018.0090) Link, Google Scholar
• 97.
  McKitterick AC, LeGault KN, Angermeyer A, Alam M, Seed KD. 2019 Competition between mobile genetic elements drives optimization of a phage-encoded CRISPR-Cas system: insights from a natural arms race. Phil. Trans. R. Soc. B 374, 20180089. (doi:10.1098/rstb.2018.0089) Google Scholar
• 98.
  Hatoum-Aslan A, Marraffini LA. 2014Impact of CRISPR immunity on the emergence and virulence of bacterial pathogens. Curr. Opin. Microbiol. 17C, 82-90. (doi:10.1016/j.mib.2013.12.001) Crossref, ISI, Google Scholar
• 99.
  Gophna U, Kristensen DM, Wolf YI, Popa O, Drevet C, Koonin EV. 2015No evidence of inhibition of horizontal gene transfer by CRISPR–Cas on evolutionary timescales. ISME J. 9, 2021-2027. (doi:10.1038/ismej.2015.20) Crossref, PubMed, ISI, Google Scholar
• 100.
  Shehreen S, Chyou T-y, Fineran PC, Brown CM. 2019Genome-wide correlation analysis suggests different roles of CRISPR-Cas systems in the acquisition of antibiotic resistance genes in diverse species. Phil. Trans. R. Soc. B 374, 20180384. (doi:10.1098/rstb.2018.0384) Link, Google Scholar
• 101.
  Ramachandran G, Bikard D. 2019Editing the microbiome the CRISPR way. Phil. Trans. R. Soc. B 374, 20180103. (doi:10.1098/rstb.2018.0103) Link, Google Scholar
• 102.
  de Graeff N, Jongsma KR, Johnston J, Hartley S, Bredenoord AL.2019The ethics of genome editing in non-human animals: a systematic review of reasons reported in the academic literature. Phil. Trans. R. Soc. B 374, 20180106. (doi:10.1098/rstb.2018.0106) Link, Google Scholar
• 103.
  Hartley S, Gillund F, van Hove L, Wickson F.2016Essential features of responsible governance of agricultural biotechnology. PLoS Biol. 14, e1002453. (doi:10.1371/journal.pbio.1002453) Crossref, PubMed, ISI, Google Scholar